メニュー 戻るLS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS28 Discussion with Patients about Rare Disease Drug Development to Improve Drug Lag in Japan

Session Chair(s)

Harumasa Nakamura, MD, PhD

Harumasa Nakamura, MD, PhD

  • Director of Clinical Research Support Office, Translational Medical Center
  • National Center of Neurology and Psychiatry, Japan

Speaker(s)

Mihoko Kobayashi

Mihoko Kobayashi

  • Japan Development Leader, Clinical Research, Rare Disease
  • Pfizer R&D Japan, Japan
Atsushi Nishizawa

Atsushi Nishizawa

  • Head of Plasma-Derived Therapies Strategy Unit
  • Takeda Pharmaceutical Company Limited, Japan
Kosuke Ito, PhD

Kosuke Ito, PhD

  • Principal Reviewer
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan